Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Brain Imaging for People at Risk of Cerebral Small Vessel Disease

Start: Nov. 8, 2022
End: March 2027
Enrollment: 50

What Is This Study About?

Damage to blood vessels in the brain can cause cerebral small vessel disease, which can lead to vascular dementia. This study will use MRI brain imaging to study changes in brain structure and brain blood vessel health over time in people at risk for developing cerebral small vessel disease. Participants will undergo three MRI brain scans during the 15-month study. Researchers will examine the brain scans to examine the progression of brain changes associated with vascular cognitive impairment and dementia.

Do I Qualify To Participate in This Study?

Minimum Age: 18 Years

Maximum Age: N/A

Must have:

  • Diagnosis of ischemic stroke (caused by a blood vessel blockage), based on clinical symptoms or brain scans
  • High blood pressure, high cholesterol, or diabetes
  • Evidence of cerebral small vessel disease on MRI brain scan

Must NOT have:

  • Unable to complete three MRI brain scans over 15 months, including any condition that may make having an MRI brain scan unsafe (e.g., metal shrapnel, heart pacemaker, severe claustrophobia, epilepsy)

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 
Study Contact
Pooja Patel

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Maryland
Kennedy Krieger Institute
Baltimore, MD 21205
Recruiting
Pooja Patel

Who Sponsors This Study?

Lead: Johns Hopkins University

Source: ClinicalTrials.gov ID: NCT05703386

 

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health